Doing CRISPR gene editing while fetuses are in the womb could make it easier to treat inherited conditions, especially those affecting tissues such as the heart or muscles.
Kiran Musunuru at the University of Pennsylvania and his colleagues have tested gene editing in monkeys, and found that it was far more effective when given before birth. “What we found was astounding,” he says. “It opens up the opportunity to treat diseases that have been very hard to treat after birth.”
Felecia Phillips Ollie DD (h.c.) is the inspiring leader and founder of The Equality Network LLC (TEN). With a background in coaching, travel, and a career in news, Felecia brings a unique perspective to promoting diversity and inclusion. Holding a Bachelor’s Degree in English/Communications, she is passionate about creating a more inclusive future. From graduating from Mississippi Valley State University to leading initiatives like the Washington State Department of Ecology’s Equal Employment Opportunity Program, Felecia is dedicated to making a positive impact. Join her journey on our blog as she shares insights and leads the charge for equity through The Equality Network.